To date, PTEN gene deletions have been extensively analyzed through FISH assays [4, 5, 20, 21], but a detailed mapping of chromosome 10 deletions that span PTEN and their impact on SCNAs and levels of aneuploidy in prostate cancer outcome have not been investigated in detail [22, 23]. This evidence concerns the gene PTEN and prostate cancer.